β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2

Kathryn DeFea(Temecula Valley Unified School District), Nigel W. Bunnett(New York University), Jonathan Zalevsky(Nektar Therapeutics (United States)), R. Dyche Mullins(Howard Hughes Medical Institute), Mark S. Thoma(University of California, San Francisco), Olivier Déry(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
The Journal of Cell Biology
March 20, 2000
Cited by 816


Related Papers